Suppr超能文献

miR-21 和 miR-143 在组织学正常至浸润性宫颈癌宫颈标本中的表达。

Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer.

机构信息

HPV Research Laboratory, UW Medicine, University of Washington, Seattle, Washington, United States of America.

出版信息

PLoS One. 2011;6(12):e28423. doi: 10.1371/journal.pone.0028423. Epub 2011 Dec 14.

Abstract

BACKGROUND

MicroRNA expression is severely disrupted in carcinogenesis, however limited evidence is available validating results from cell-line models in human clinical cancer specimens. MicroRNA-21 (mir-21) and microRNA-143 (mir-143) have previously been identified as significantly deregulated in a range of cancers including cervical cancer. Our goal was to investigate the expression patterns of several well-studied microRNA species in cervical samples and compare the results to cell line samples.

METHODOLOGY/PRINCIPAL FINDINGS: We measured the expression of mir-21 and mir-143 in 142 formalin-fixed, paraffin embedded (FFPE) cervical biopsy tissue blocks, collected from Dantec Oncology Clinic, Dakar, Senegal. MicroRNA expression analysis was performed using Taqman-based real-time PCR assays. Protein immunohistochemical staining was also performed to investigate target protein expression on 72 samples. We found that mir-21 expression increased with worsening clinical diagnosis but that mir-143 was not correlated with histology. These observations were in stark contrast to previous reports involving cervical cancer cell lines in which mir-143 was consistently down-regulated but mir-21 largely unaffected. We also identified, for the first time, that cytoplasmic expression of Programmed Cell Death Protein 4 PDCD4; a known target of mir-21) was significantly lower in women with invasive cervical carcinoma (ICC) in comparison to those with cervical intraepithelial neoplasia (2-3) or carcinoma in situ (CIN2-3/CIS), although there was no significant correlation between mir-21 and PDCD4 expression, despite previous studies identifying PDCD4 transcript as a known mir-21 target.

CONCLUSIONS

Whilst microRNA biomarkers have a number of promising features, more studies on expression levels in histologically defined clinical specimens are required to investigate clinical relevance of discovery-based studies. Mir-21 may be of some utility in predictive screening, given that we observed a significant correlation between mir-21 expression level and worsening histological diagnosis of cervical cancer.

摘要

背景

微小 RNA 表达在癌变过程中受到严重干扰,然而,在人类临床癌症标本中验证细胞系模型结果的证据有限。微小 RNA-21(mir-21)和微小 RNA-143(mir-143)以前在多种癌症中被发现存在显著失调,包括宫颈癌。我们的目标是研究几种经过充分研究的微小 RNA 物种在宫颈样本中的表达模式,并将结果与细胞系样本进行比较。

方法/主要发现:我们测量了 142 个来自塞内加尔达喀尔 Dantec 肿瘤学诊所的福尔马林固定、石蜡包埋(FFPE)宫颈活检组织块中 mir-21 和 mir-143 的表达。使用 Taqman 基于实时 PCR 检测进行微 RNA 表达分析。还对 72 个样本进行了蛋白质免疫组织化学染色,以研究靶蛋白的表达。我们发现 mir-21 的表达随着临床诊断的恶化而增加,但 mir-143 与组织学无关。这些观察结果与涉及宫颈癌细胞系的先前报告形成鲜明对比,在这些报告中,mir-143 始终被下调,但 mir-21 基本不受影响。我们还首次发现,已知 mir-21 靶标的程序性细胞死亡蛋白 4(PDCD4)的细胞质表达在浸润性宫颈癌(ICC)妇女中明显低于宫颈上皮内瘤变(2-3)或原位癌(CIN2-3/CIS)患者,尽管 mir-21 与 PDCD4 表达之间没有显著相关性,尽管先前的研究确定 PDCD4 转录物是已知的 mir-21 靶标。

结论

虽然微 RNA 生物标志物具有许多有前途的特征,但需要对组织学定义的临床标本中的表达水平进行更多研究,以研究基于发现的研究的临床相关性。鉴于我们观察到 mir-21 表达水平与宫颈癌组织学诊断恶化之间存在显著相关性,mir-21 可能在预测性筛查中具有一定的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6be/3237431/76eb534b0cde/pone.0028423.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验